BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 9557639)

  • 1. Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor.
    Neff S; Sá-Carvalho D; Rieder E; Mason PW; Blystone SD; Brown EJ; Baxt B
    J Virol; 1998 May; 72(5):3587-94. PubMed ID: 9557639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage.
    Baranowski E; Ruiz-Jarabo CM; Sevilla N; Andreu D; Beck E; Domingo E
    J Virol; 2000 Feb; 74(4):1641-7. PubMed ID: 10644333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-efficiency utilization of the bovine integrin alpha(v)beta(3) as a receptor for foot-and-mouth disease virus is dependent on the bovine beta(3) subunit.
    Neff S; Mason PW; Baxt B
    J Virol; 2000 Aug; 74(16):7298-306. PubMed ID: 10906183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine-glycine-aspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin alpha(v)beta3 in vitro.
    Jackson T; Sharma A; Ghazaleh RA; Blakemore WE; Ellard FM; Simmons DL; Newman JW; Stuart DI; King AM
    J Virol; 1997 Nov; 71(11):8357-61. PubMed ID: 9343190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate.
    Jackson T; Ellard FM; Ghazaleh RA; Brookes SM; Blakemore WE; Corteyn AH; Stuart DI; Newman JW; King AM
    J Virol; 1996 Aug; 70(8):5282-7. PubMed ID: 8764038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of two amino acid substitutions in the capsid proteins on the interaction of two cell-adapted PanAsia-1 strains of foot-and-mouth disease virus serotype O with heparan sulfate receptor.
    Bai X; Bao H; Li P; Wei W; Zhang M; Sun P; Cao Y; Lu Z; Fu Y; Xie B; Chen Y; Li D; Luo J; Liu Z
    Virol J; 2014 Jul; 11():132. PubMed ID: 25056022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle.
    Sa-Carvalho D; Rieder E; Baxt B; Rodarte R; Tanuri A; Mason PW
    J Virol; 1997 Jul; 71(7):5115-23. PubMed ID: 9188578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparan sulfate-binding foot-and-mouth disease virus enters cells via caveola-mediated endocytosis.
    O'Donnell V; Larocco M; Baxt B
    J Virol; 2008 Sep; 82(18):9075-85. PubMed ID: 18614639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple virulence determinants of foot-and-mouth disease virus in cell culture.
    Baranowski E; Sevilla N; Verdaguer N; Ruiz-Jarabo CM; Beck E; Domingo E
    J Virol; 1998 Aug; 72(8):6362-72. PubMed ID: 9658076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examination of soluble integrin resistant mutants of foot-and-mouth disease virus.
    Lawrence P; LaRocco M; Baxt B; Rieder E
    Virol J; 2013 Jan; 10():2. PubMed ID: 23282061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to the vitronectin receptor (integrin alpha V beta 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells.
    Berinstein A; Roivainen M; Hovi T; Mason PW; Baxt B
    J Virol; 1995 Apr; 69(4):2664-6. PubMed ID: 7533862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ability of integrin alpha(v)beta(3) To function as a receptor for foot-and-mouth disease virus is not dependent on the presence of complete subunit cytoplasmic domains.
    Neff S; Baxt B
    J Virol; 2001 Jan; 75(1):527-32. PubMed ID: 11119622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor.
    Klimstra WB; Ryman KD; Johnston RE
    J Virol; 1998 Sep; 72(9):7357-66. PubMed ID: 9696832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of foot-and-mouth disease virus with soluble bovine alphaVbeta3 and alphaVbeta6 integrins.
    Duque H; LaRocco M; Golde WT; Baxt B
    J Virol; 2004 Sep; 78(18):9773-81. PubMed ID: 15331710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positively charged residues at the five-fold symmetry axis of cell culture-adapted foot-and-mouth disease virus permit novel receptor interactions.
    Berryman S; Clark S; Kakker NK; Silk R; Seago J; Wadsworth J; Chamberlain K; Knowles NJ; Jackson T
    J Virol; 2013 Aug; 87(15):8735-44. PubMed ID: 23740982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance to mutations in the foot-and-mouth disease virus integrin-binding RGD region is different in cultured cells and in vivo and depends on the capsid sequence context.
    Gutiérrez-Rivas M; Pulido MR; Baranowski E; Sobrino F; Sáiz M
    J Gen Virol; 2008 Oct; 89(Pt 10):2531-2539. PubMed ID: 18796722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foot-and-mouth disease virus receptors: comparison of bovine alpha(V) integrin utilization by type A and O viruses.
    Duque H; Baxt B
    J Virol; 2003 Feb; 77(4):2500-11. PubMed ID: 12551988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid selection in modified BHK-21 cells of a foot-and-mouth disease virus variant showing alterations in cell tropism.
    Escarmís C; Carrillo EC; Ferrer M; Arriaza JF; Lopez N; Tami C; Verdaguer N; Domingo E; Franze-Fernández MT
    J Virol; 1998 Dec; 72(12):10171-9. PubMed ID: 9811758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of beta2-microglobulin and integrin alphavbeta3 molecules in the coxsackievirus A9 infectious cycle.
    Triantafilou M; Triantafilou K; Wilson KM; Takada Y; Fernandez N; Stanway G
    J Gen Virol; 1999 Oct; 80 ( Pt 10)():2591-2600. PubMed ID: 10573151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propagation of an attenuated virus by design: engineering a novel receptor for a noninfectious foot-and-mouth disease virus.
    Rieder E; Berinstein A; Baxt B; Kang A; Mason PW
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10428-33. PubMed ID: 8816817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.